当前位置:首页 - 行情中心 - 复星医药(600196) - 财务分析 - 利润表

复星医药

(600196)

24.86

0.49  (2.01%)

今开:24.33最高:25.00成交:11.67万手 市盈:0.00 上证指数:3123.14   0.70%2017-01-20
昨收:24.37 最低:24.33 换手:0.00%振幅:0.00 深证指数:9906.14  1.41%15:30:59

集合

竞价

利润表

按照会计年度查询:
报告期2016-09-302016-06-302016-03-312015-12-31
一、营业总收入10,637,985,4626,937,091,238.453,226,040,690.5212,608,648,314.38
营业收入10,637,985,4626,937,091,238.453,226,040,690.5212,608,648,314.38
二、营业总成本9,512,363,248.736,159,446,501.122,888,139,056.911,655,880,500.15
营业成本4,915,105,208.323,228,574,506.971,560,156,6976,308,040,687.96
营业税金及附加86,547,506.2859,225,933.4626,138,487.73106,485,254.66
销售费用2,639,501,550.341,679,760,685.16758,025,326.12,815,141,395.08
管理费用1,525,389,484.26970,947,149.23442,287,426.31,905,522,063.16
财务费用319,329,904.69198,372,474.29100,816,157.02450,235,338.56
资产减值损失26,489,594.8422,565,752.01714,962.7570,455,760.73
三、其他经营收益-169,063,311.66-78,201,676.16-93,184,270.62-193,246,697.52
允许价值变动净收益3,345,092.31-7,414,661.04-4,713,785.57-2,218,433.18
投资净收益1,565,442,784.231,078,798,670.82491,892,235.072,346,622,801.73
联营、合营企业投资收益1,035,810,577.66717,195,928.76276,926,240.791,107,466,995.79
汇兑净收益--------
四、营业利润2,694,410,089.811,849,028,747.11825,080,083.123,297,172,182.78
营业外收入157,664,123.7287,474,740.9133,381,355.27106,660,911.57
营业外支出14,266,811.616,732,791.24892,739.6132,001,555.9
非流动资产处置净损失5,404,663.433,686,774.12160,554.363,620,027.46
五、利润总额2,837,807,401.921,929,770,696.78857,568,698.783,371,831,538.45
所得税305,000,525.21181,145,208.295,758,837.62501,170,684.08
未确认的投资损失--------
六、净利润(百万元)2,176.891,500.27634.232,460.09
少数股东损益355,918,128.76248,359,081.01127,578,035.45410,567,270.79
归属于母公司股东的净利润2,176,888,747.951,500,266,407.57634,231,825.712,460,093,583.58
七、每股收益0.940.650.271.07
基本每股收益0.940.650.271.07
稀释每股收益0.940.650.271.06
TOP↑